Health In Tech Announces $7 Million PIPE Financing

Health In Tech, Inc. Class A ( (HIT) ) has provided an announcement.

On March 25, 2026, Health In Tech, Inc., an AI-enabled InsurTech platform focused on self-funded employer health plans and automated underwriting solutions, entered into a securities purchase agreement for a private investment in public equity financing. The company operates a marketplace that connects brokers, TPAs, MGUs and carriers, enabling customized self-funded plans, bindable stop-loss quotes and integrated claims administration, and it targets increased efficiency across the health insurance value chain.

In the March 25, 2026 transaction, Health In Tech agreed to sell 5,600,000 common shares at $1.25 per share in a PIPE expected to raise approximately $7.0 million in gross proceeds, with closing anticipated on or about March 27, 2026, subject to customary conditions. The company plans to use the funds to expand sales distribution, advance its technology and new product development and bolster working capital, while granting PIPE investors resale registration rights, steps that collectively strengthen its capital position and support ongoing growth initiatives in the competitive InsurTech market.

The shares in the PIPE were issued in a private placement to accredited investors under exemptions from U.S. securities registration requirements, and Craig-Hallum Capital Group LLC served as sole placement agent and arranged customary lock-up agreements from directors and officers. By structuring the deal as a PIPE with subsequent resale registration obligations, Health In Tech is balancing the need for timely capital to fund expansion against future potential dilution and secondary-market supply that existing shareholders and prospective investors will monitor closely.

The most recent analyst rating on (HIT) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Health In Tech, Inc. Class A stock, see the HIT Stock Forecast page.

Spark’s Take on HIT Stock

According to Spark, TipRanks’ AI Analyst, HIT is a Outperform.

The score is driven primarily by solid underlying financial health (minimal leverage and improving cash flow) and a constructive earnings outlook with strong 2026 growth guidance. Offsetting these positives are a demanding valuation (high P/E, no dividend yield provided) and only moderate technical strength given the stock is still below its 200-day average.

To see Spark’s full report on HIT stock, click here.

More about Health In Tech, Inc. Class A

Health In Tech, Inc. is an AI-enabled InsurTech platform company that operates a marketplace aimed at streamlining processes in the health insurance industry through vertical integration, process simplification and automation. Its platform connects brokers, third-party administrators, managing general underwriters and carriers to provide customized self-funded health plans, bindable stop-loss quotes, AI-driven underwriting, and integrated claims administration and reporting for employer-sponsored health coverage.

By targeting friction points in underwriting, sales and service for self-funded health insurance, Health In Tech focuses on improving efficiency for insurance ecosystem participants while expanding access to employer self-funded health solutions. This positioning places the company at the intersection of health insurance and financial technology, where automation and data-driven tools are reshaping how coverage is designed and administered.

Average Trading Volume: 358,940

Technical Sentiment Signal: Sell

Current Market Cap: $103M

For detailed information about HIT stock, go to TipRanks’ Stock Analysis page.